Metabolic Syndrome and Drug Therapy is a peer reviewed open access journal providing endocrinologists, diabetes specialists, and related healthcare professionals with multidisciplinary original research on the latest treatments for patients with this condition as well as the resultant disease states. Metabolic Syndrome is a disorder of increasing prevalence and is diagnosed by occurrence of multiple conditions in a single patient, including abdominal obesity, high blood pressure, elevated glucose levels, high levels of triglycerides, and low levels of high-density cholesterol (HDL). This condition puts patients at high risk of developing a number of conditions, particularly cardiovascular disease and diabetes.
Metabolic Syndrome and Drug Therapy is dedicated to publishing the latest comprehensive, practical information to assist physicians in making treatment decisions for these patients. Articles are published continuously online, and occasionally in print.